For those people who could not attend the congress in Boston, the 1st Vaccine Virtual Congress was offered.
This innovative alternative was very well received and enabled access to relevant research and the opportunity to connect with other vaccinologists.
The 2nd Vaccine Global Congress, organized in collaboration with the International Society for Vaccines (www.isv-online.org), attracted a mix of scientists, governmental authorities and healthcare workers and provided a broad state-of-the-art report. The scene was set by presentations on vaccines for the main infectious diseases HIV/AIDS, Malaria and Tuberculosis which kill 5 million people each year. Next to these major disease targets, sessions addressed topics such as cancer vaccines, adjuvants, delivery systems, vaccine policy and public health issues.
“I was delighted to see so many people from different areas, all with the common objective of accelerating progress in the research, development and delivery of vaccines”, said Professor Shan Lu from the University of Massachusetts Medical School in Worchester MA, USA and co-chairman of the congress; “The science presented was excellent and will form the basis for an increasingly needed prophylactic approach to healthcare”.
With over 1100 pre-registrants, the 1st Vaccine Virtual Congress was also considered a huge success. Academics in research and development, regulatory and governmental agencies, charities, and health and industry professionals attended the congress from their desk at home or in the office. They were able to join live keynote presentations and submit questions in real time, review and download posters, network and chat with their online peers, and navigate the show via a virtual fully interactive platform.
“Together with ON24, the global leader in webcasting and virtual events solutions, we were able to create an interactive environment where delegates could access educational information and collaborate with peers regardless of physical boundaries, said Nigel Clair, Commercial Director of Elsevier, “in addition, people who registered can still access the content for another 3 months”. Registration for the Vaccine Virtual Congress is still possible and free (www.vaccinecongress.com).
“As a professional congress organizer Elsevier is always aiming to provide delegates an excellent environment to hear presentations, network with peers and access rich information”, said Nigel, “specifically, we will continue to strengthen our relationship with the important vaccine community and I already look forward to the 3rd Vaccine Global Congress that will be held early October 2009 in Bangkok, Thailand”.
Floris de Hon | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences